GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 209 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,486,000 | -51.8% | 6,850 | -74.3% | 0.01% | -55.6% |
Q4 2020 | $3,080,000 | +7.0% | 26,688 | -9.7% | 0.02% | -5.3% |
Q3 2020 | $2,878,000 | +15.1% | 29,567 | +45.1% | 0.02% | 0.0% |
Q2 2020 | $2,500,000 | +33.5% | 20,375 | -4.7% | 0.02% | +5.6% |
Q1 2020 | $1,873,000 | +66.0% | 21,383 | +98.3% | 0.02% | +100.0% |
Q4 2019 | $1,128,000 | +0.3% | 10,785 | +10.3% | 0.01% | -10.0% |
Q3 2019 | $1,125,000 | -36.7% | 9,776 | -5.1% | 0.01% | -37.5% |
Q2 2019 | $1,777,000 | -5.4% | 10,306 | -7.5% | 0.02% | -11.1% |
Q1 2019 | $1,879,000 | +85.5% | 11,144 | +7.2% | 0.02% | +63.6% |
Q4 2018 | $1,013,000 | +1.6% | 10,400 | +80.2% | 0.01% | +10.0% |
Q3 2018 | $997,000 | +25.9% | 5,770 | +1.6% | 0.01% | +25.0% |
Q2 2018 | $792,000 | +106.2% | 5,679 | +66.7% | 0.01% | +100.0% |
Q1 2018 | $384,000 | +33.3% | 3,406 | +56.1% | 0.00% | +33.3% |
Q4 2017 | $288,000 | +23.1% | 2,182 | -5.5% | 0.00% | 0.0% |
Q3 2017 | $234,000 | +9.9% | 2,309 | +8.9% | 0.00% | 0.0% |
Q2 2017 | $213,000 | -1.4% | 2,120 | -20.5% | 0.00% | -50.0% |
Q3 2014 | $216,000 | – | 2,668 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|